Denali Therapeutics Inc. (DNLI)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Takeda Collaboration Revenue	-	10.00M	51.92M
Sanofi Collaboration Revenue	-	25.00M	53.40M
Biogen Collaboration Revenue	295.79M	295.53M	3.15M
Revenue (Total)	-	330.53M	-

Data Source: Fiscal.ai Last updated: Aug 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 12, 2026

Data Sources Report a data error